Table 3—

Factor analysis of repertoires of immunoglobulin(Ig)G and IgM from the sera of idiopathic pulmonary arterial hypertension (IPAH) patients, systemic scleroderma (SSc) patients with or without pulmonary arterial hypertension (PAH) and their respective controls, on normal human fibroblasts and human epithelial (HEp)-2 cell antigens

Antigen sourceIsotypeFactorPAH versus controlsIPAH versus controlsSSc PAH versus controls
Molecular weights kDap-valueMolecular weights kDap-valueMolecular weights kDap-value
IgG130, 35, 40, 60<0.001#30, 35, 40, 60<0.001#30, 35, 40, 60, 950.557
225, 95<0.00125, 95<0.001#25, 600.084
FibroblastsIgM165, 700.003#25, 30, 35, 950.008#25, 30, 50, 75, 850.275
235, 400.003#40, 700.023#25, 35, 400.922
370, 950.45650, 75, 85<0.001#70, 950.922
IgG125, 30, 35, 50, 75, 850.36765, 700.36765, 700.367
235,400.79545, 650.79545, 650.795
370, 950.12225, 350.12225, 350.122
HEp-2 cellsIgM135, 45, 50, 73, 750.130, 45, 50, 73, 750.0655, 65, 70, 750.37
255, 65, 700.2725, 300.2425, 30, 35, 45, 50, 73, 750.85
325, 300.6355, 650.23
  • #: level of significance of the comparison of the factor scores of patients with controls using a paired Wilcoxon test.